DexCom ( DXCM -2.62%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels. But the stock has been performing poorly this year amid ...

The Apple Watch integration with the Dexcom G7 continuous glucose monitor (CGM) has revolutionized diabetes management. With the best Apple Watch models, users can view real-time blood sugar data ...

Maintaining stable glucose levels is essential for your overall health, whether or not you have diabetes. Here's ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...

Biosensors that measure glucose are now available without a prescription. Wearing one was an emotional roller coaster ride.

Adults in the US who want to measure their blood glucose levels ... The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription ...

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

About DexCom, Inc. DexCom ... If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider.

DexCom has helped revolutionize diabetes care with continuous glucose monitoring (CGM) devices. Patients wear a patch that continuously transmits blood sugar data to a device or smartphone.

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the back of a person's arm and steadily measure their blood sugar ...